Research Ethics in Clinical Pharmacology Tens of thousands of clinical trials involving drugs are taking place each year. When the researchers are clinicians, they often recruit amongst their patients. Given […]
Introduction For the past two decades in Canada, patient groups funded by pharmaceutical companies have dominated public conversations about the effectiveness and safety of prescription drugs. These groups receive unrestricted […]
Adverse drug reactions (ADRs) are an important part of the process of determining the safety of drugs and treatments. Reports of ADRs by consumers has become a significant portion of the total yet only 1-5% of ADRs are ever reported. The consumer has the biggest stake in ensuring that ADRs are documented and that pharmaceutical manufacturers are held accountable for their mistakes.
One individual broke away from the standard Lipitor “solution” when he experienced continued side-effects from the treatment and began to follow a health alternative including changes in diet and lifestyle. His success is a living example that alternatives not only exist but are obtainable.
Around the globe, medicines regulators approve new drugs after reviewing data from clinical trials. It is these trial data that underlie assuring determinations, like those made by the US Food […]
An examination of compulsive hoarding in light of upgrading it to its own classification in the newest DSM release.
Calls for a Homeland Security approach to mental illness provides for the creation of an “at risk” population that is not only treatable but incurable…and highly profitable.